Project Summary
Primal Organix has created the world’s first all-natural mental health supplement:
1. Assisted over 13,000 customers suffering from mental health challenges.
2. Proven to manage anxiety in 60 seconds
3. Advancing to Phase I clinical trials. This is the primary driver of the capital raise to accelerate revenue and profit growth.
4. Substantial distribution upside with clinical trial success but already growing at a steady pace
5. $1Mpa+ in sales revenue
6. Established capacity to supply over 7,000 pharmacies and other healthcare professionals across Australia and further
7. Forecasting based on growth in distribution is $100M revenue in 3-4 years
8. IPO or trade sale to follow successfully reaching the above target
Project description
Manufacturing facility – Perth. National distribution. Forecasting international.
Following substantial growth in distribution, gathering further interest and orders through our marketing, we are presenting this joint investment opportunity for Wholesale Investors.
Primal Organix has created the world’s first all-natural mental health supplement suite that has:
1. Assisted over 13,000 customers suffering from mental health challenges. Primary product is anxiety relief but also includes sleep assistance amongst an 18 strong product suite
2. Proven to manage anxiety in 60 seconds
3. Advancing to Phase I clinical trials. This is the primary driver of the capital raise to accelerate revenue and profit growth. See the attached.
4. Substantial distribution upside with clinical trial success but already growing at a steady pace
5. $1Mpa+ in sales revenue
6. Established capacity to supply over 7,000 pharmacies and other healthcare professionals across Australia and further
7. Forecasting based on growth in distribution is $100M revenue in 3-4 years
8. IPO or trade sale to follow successfully reaching the above target
Investor information
Financial information
Investment sought: $550,000-9,950,000
Document(s) / Video(s):
Project information
Project highlights:
Current capital raising AUD9.744
The company is offering sophisticated investors an equity position in Primal Organix
19.488 million newly issued shares @ $0.50 AUD per share
Project timeline:
Expected start date:
05 April, 2023
Expected end date:
30 June, 2023
Funding round finish date:
30 June, 2023
Request more information
Please fill in the form below. Mandatory fields are marked with
"*" indicates required fields
